Morgan Stanley Call 130 XYL 20.09.../ DE000ME9GUC1 /
31/05/2024 20:58:16 | Var.-0.06 | Denaro22:00:34 | Lettera22:00:34 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.34EUR | -4.29% | - Quantità in denaro: - |
- Quantità in lettera: - |
Xylem Inc | 130.00 USD | 20/09/2024 | Call |
GlobeNewswire
15:01
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolima...
GlobeNewswire
14:56
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
GlobeNewswire
14:52
NVIDIA Robotics Adopted by Industry Leaders for Development of Tens of Millions of AI-Powered Autono...
GlobeNewswire
14:44
Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and Omn...
GlobeNewswire
14:35
Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolu...
GlobeNewswire
14:23
GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors...
GlobeNewswire
14:13
NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developer...
GlobeNewswire
14:11
NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars
GlobeNewswire
14:00
CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
GlobeNewswire
14:00
Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an ...